Stimulation of the CD2 receptor pathway induces apoptosis in human T lymphotropic virus type I-infected cell lines

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 4, 1996, Pages 317-325

  Guyot, Deborah J ^a   Joseph Trask, O ^b   Andrews, Janice M ^a   Newbound, Garret C ^a   Lairmore, Michael D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; CD2; CD3; Human T lymphotropic virus type I

Indexed keywords

CD2 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 2; RECOMBINANT INTERLEUKIN 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MITOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INHIBITION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LYMPHOTROPIC VIRUS TYPE I; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 9244239221     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199604010-00001     Document Type: Article

References (62)

1. Williams G. Programmed cell death: apoptosis and oncogenesis. Cell 1991;65:1097.
2. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Intl Rev Cytol 1980;68:251.
3. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell 1994;76:777-9.
4. Kerr AR, Wylie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide range implications in tissue kinetics. Br J Cancer 1972;26:239.
5. Smith CA, Williams GT, Kingston R, Jenkinson E, Owen JJT. Antibodies to CD3/TCR receptor complex induce cell death by apoptosis in immature T cells in thymic cultures. Nature 1989;337:181-4.
6. Wesselborg S, Janssen O, Kabelitz D. Induction of activation driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993;150:4338-45.
7. Schraven B, Wild M, Kirchgessner H, et al. Alterations of CD2 association with T cell receptor signalling molecules in "CD2 unresponsive" human T lymphocytes. Eur J Immunol 1993;23:119-23.
8. Janssen O, Wesselborg S, Heckl-Östricher B, et al. TCR/CD3 signalling induces death by apoptosis in human TCR γ/δ T cells. J Immunol 1991;146:35-9.
9. - subsets. Immunology 1992;75:305-10.
10. Wesselborg S, Prüfer U, Wild M, Schraven B, Meuer SC, Kabelitz D. Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 1993;23:2707-10.
11. McConkey D, Fosdick L, D'Adamio L, Jondol M, Orrenius S. Co-receptor (CD4/CD8) engagement enhances CD3-induced apoptosis in thymocytes. J Immunol 1994;153:2436-43.
12. Franco M-D, Nunès J, Boursier J, et al. Regions of the CD8 molecule involved in the regulation of CD2-mediated activation. Cell Immunol 1994;157:341-52.
13. Böhmig G, Kovarik J, Holter W, Pohanka E, Zlabinger G. Specific down-regulation of proliferating T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM1 in vitro. J Immunol 1994;152:3720-8.
14. Schwartz RH. A cell culture model for T lymphocyte clonal energy. Science 1990;248:1349-56.
15. Gückel B, Bereck C, Lutz M, Altevogt P, Schirrmacher V, Kyewski B. Anti-CD2 antibody induces T cell unresponsiveness in vivo. J Exp Med 1991;174:957-67.
16. Reed JC, Tadmori W, Kamoun M, Koretzky G, Nowell PC. Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 kd protein associated with the sheep erythrocyte receptor on human T lymphocytes. J Immunol 1985;134:1631-9.
17. Rouleau M, Mollereau B, Bernard A, et al. Mitogenic CD2 mAb pairs predispose peripheral T cells to undergo apoptosis on interaction with a third CD2 mAb. J Immunol 1994;152:4861-72.
18. Khabbaz R, Darrow W, Hartley T, et al. Seroprevalence and risk factors among patients in an inner city emergency department. JAMA 1990;283:60-4.
19. Blattner W. Retroviruses. In: Viral infections of humans: epidemiology and control, 3rd ed. New York: Plenum Publishing Corp., 1989:545.
20. Gazzolo L, Robert-Guroff M, Jennings A, Duc Dodon M, Najberg G, De Thé G. Type I and type III HTLV-Ab in hospitalized and out-patient Zairians. Intl J Cancer 1985;36:373-8.
21. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JO, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9.
22. Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Adult T cell leukemia in Japan. In: Seno S, Takaku F, Irino S, eds. Topics in hematology. Amsterdam: Excerpta Medica, 1977:73.
23. Yoshida M, Miyoshi I, Hinuma Y. Isolation and characterization of retrovirus from cell lines of adult T cell leukemia and its implications in the disease. Proc Natl Acad Sci USA 1982;79:2031-5.
24. Hinuma Y, Nagata K, Hanoaka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981;78:6476-80.
25. Osame M, Usuku K, Izumo S, et al. HTLV-I-associated myelopathy, a new clinical entity. Lancet 1986;1:1031-2.
26. Gessain A, Barin F, Vernant J, et al. Antibodies to human T-lymphotropic virus type 1 in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
27. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakauima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989;1:411.
28. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-I and polymyositis in Jamaica. Lancet 1989;2:1184-7.
29. Mochizuki M, Watanabe T, Yamaguchi K. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 1992;83:236-9.
30. Gazzalo L, Duc Dudon M. Direct activation of resting T cells by HTLV-I. Nature [London] 1987;326:714-7.
31. Duc Dodon M, Bernard A, Gazzalo L. Peripheral T cell activation by HTLV-I interferes with the CD2 but not the CD3/TCR pathway. J Virol 1989;63:5413-9.
32. Kimata JT, Palker TJ, Ratner L. The mitogenic activity of HTLV-I is T cell associated and requires the CD2/LFA3 activation pathway. J Virol 1993;67:3134-41.
33. Kawano F, Tsukamoto A, Satoh M. Poorly expressed CD2 antigen on the leukemic cells of adult T cell leukemia implicate a more aggressive clinical course. Leukemia Res 1990;14:1071.
34. McKendall R, Oas J, Lairmore M. HTLV-I-associated myelopathy endemic in Texas-born residents and isolation of virus from cerebral spinal fluid cells. Neurology 1991;41:831-6.
35. Kaplan J, Litchfield B, Roualt C, et al. HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient. Neurology 1991;42:192-7.
36. Ratner L, Heyden NV, Paine E, et al. Familial adult T cell leukemia/lymphoma. Am J Hematol 1990;34:215-22.
37. Rowe T, Dezzutti C, Guenthner PC, et al. Characterization of an HTLV-I-infected cell line derived from a patient with adult T-cell leukemia with stable co-expression on CD4 and CD8. Leukemia Res (in press).
38. Popovic M, Sarin PS, Robert-Gurrof M, et al. Isolation and transmission of human retrovirus (human T-cell leukemia virus). Science 1983;219:856-9.
39. Miyoshi I, Kubonishi I, Yoshimoto S, et al. Type C virus particles in cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukemia T cells. Nature [London] 1981;294:770-1.
40. Mentz F, Ouaaz F, Michel A, et al. Maturation of acute lymphoblastic leukemia cells after CD2 ligation and subsequent treatment with IL-2. Blood 1994;84:1182-92.
41. Tsuda H, Huang R-W, Takatsuki K. Interleukin-2 prevents programmed cell death in adult T cell leukemia cells. Jpn J Cancer Res 1993;84:431-7.
42. Duke RC, Cohen JJ. IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res 1986;5:289-99.
43. Duvall E, Wyllie AH. Death and the cell. Immunol Today 1986;7:115.
44. Cohen J. Apoptosis. Immunol Today 1993;14:126.
45. Gorezyca W, Bruno S, Darzynkiewiecz RJ, Gong J, Darzynkiewiecz Z. DNA strand breaks occurring during apoptosis: their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Intl J Oncol 1992;1:639.
46. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of IL-2R gene expression by p40× encoded by HTLV-I. Embo J 1986;5:2883-8.
47. Ballard DW, Boehnlein E, Lowenthal JW, Wano Y, Franza BR, Greene WC. HTLV-I tax induces cellular proteins that activate the KB element in the IL-2 receptor α gene. Science 1988;241:1652-5.
48. Ruben S, Poteat H, Tan T-H, et al. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-I tax gene product. Science 1988;241:89-92.
49. Bierer BE, Schreiber SL, Burakoff SJ. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation. Eur J Immunol 1991;21:439-45.
50. Sehajpal PK, Sharma VK, Ingulli E, Stenzel KH, Suthanthiran M. Synergism between the CD3 antigen- and CD2 antigen-derived signals. Transplantation 1993;55:1118-24.
51. Zacharchuk CM, Merćep M, Chakraborti PK, Simons Jr, SS, Ashwell JD. Programmed T lymphocyte death: cell activation and steroid induced pathways are mutually antagonistic. J Immunol 1990;145:4037-45.
52. Shi Y, Sahai BM, Green DR. Cyclosporin A inhibits activation-induced cell death in T cell hybridomas and in thymocytes. Nature 1989;339:625-6.
53. Carmo AM, Mason DW, Beyers AD. Physical association of the cytoplasmic domain of CD2 with the tyrosine kinases p56lck and p59fyn. Eur J Immunol 1993;23:2196-201.
54. lck. Eur J Immunol 1992;22:2915-21.
55. Tendler CL, Greenburg SJ, Blattner WA, et al. Transactivation of IL-2 and its receptor induces immune activation in HTLV-I associated mylopathy. pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 1990;87:5218-22.
56. Chlichlia K, Moldenhauer G, Daniel PT, et al. Immediate effects of reversible HTLV-I tax function: T cell activation and apoptosis. Oncogene 1995;10:269.
57. Kronke M, Leonard WJ, Depper JM, et al. Cyclosporin A inhibition of T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 1984;81:5214-8.
58. McGuire KL, Curtis VE, Larson EL, Haseltine WA. Influence of HTLV-I tax and rex on IL-2 gene expression. J Virol 1993;67:1590-9.
59. Mann DL, Martin P, Hamlin-Green G, Nalewaik R, Blattner W. Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes. Clin Immunol Immunopathol 1994;72:312-20.
60. Trauth BC, Klas C, Peters AMJ, et al. Monoclonal antibody-mediated tumor regression by apoptosis. Science 1989;245:301-5.
61. Debatin K-M, Goldman CK, Waldmann TA, Krammer PH. APO-1-induced apoptosis of leukemia cells from patients with adult T cell leukemia. Blood 1993;81:2972-7.
62. Copeland KFT, Haaksma A, Goudsmit J, Krammer PH, Heeney J. Inhibition of apoptosis in T cells expressing HTLV-I tax. AIDS Res Hum Retrovir 1994;10:1259-68.